Search Results

Home → Flash News → Started in medicinal chemistry. Got hooked on ligand design. Dr. Meet Celtarys and learn more about its leading work on ligand-linker-fluorophore chemistry 🚀 ✳️ Listen GPCR Podcast Started in medicinal chemistry. Got hooked on ligand design. Dr. Meet Celtarys and learn more about its leading work on ligand-linker-fluorophore chemistry 🚀 ✳️ Listen

He subsequently returned to Munich as a research associate at the Institute of Pharmaceutical Chemistry Habilitus, he was appointed at the University of Bonn as a Professor of Pharmaceutical Chemistry declining Peter has been chaired Full Professor of Pharmaceutical / Medicinal Chemistry at the Friedrich-Alexander University Erlangen-Nürnberg and declined an offer for the Chair for Pharmaceutical Chemistry at the Peter Gmeiner has been spokesman of the Research Training Group "Medicinal Chemistry of Selective GPCR

Antonella trained as a medicinal chemist in Italy, followed by a Ph.D. in computational medicinal chemistry

Podcast Strategic Partners Eleonora Comeo About this episode Eleonora Comeo is a doctoral candidate in Medicinal Chemistry and Drug Discovery in the joint program of the University of Nottingham in the UK and Monash

Jacobson received his BA in Liberal Arts from Reed College in 1976 and his Ph.D. in Chemistry from the currently the Senior Investigator and Chief of the Molecular Recognition Section, Laboratory of Bioorganic Chemistry His numerous awards include: 2008 Sato Award; 2009 Medicinal Chemistry Hall of Fame (American Chemical

From 2015 to 2019, he completed his Ph.D. in the Medicinal Chemistry group at VU University Amsterdam Timo De Groof on the web LinkedIn Researchgate Twitter Medical Imaging Group Google Scholar Dr.

Arthur Christopoulos of Monash University in Australia, one of the pioneers in the medicinal chemistry

GPCR x Celtarys Reseach Empowering medicinal biochemists Celtarys empowers medicinal biochemists by providing Maria Majellaro earned her degree in Pharmaceutical Chemistry and Technology from the University of Bari and completed her PhD in Biomolecular Sciences in Pharmacology and Medicine as “Doctor Europeus” in Her work focuses on organic synthesis, medicinal chemistry, and the development of GPCR-targeted tools Maria Majellaro "We always start with the problem, then generate the right compound using our chemistry

She began as a medicinal chemist in Italy, but a postdoc opportunity in Santiago de Compostela—and a Pivoting: From Chemistry Company to Discovery Partner Initially focused on tool production, Celtarys “We always start with the problem, then generate the right compound using our chemistry. Together, we’re combining chemistry, biology, and business insight to empower the GPCR research community Her scientific expertise is rooted in organic synthesis and medicinal chemistry, with a particular focus

That opened up a new world.” – Alessandro Nicoli That early spark led him to discover the role of medicinal chemistry and, eventually, molecular modeling. For Nicoli, chemistry became more than reactions—it became a bridge to biological insight. 3. Nicoli dove into computational chemistry. “We’re living in a golden era for computational chemistry… the tools are out there.

computational and mathematical modelling, structural and chemical biology, molecular and cellular pharmacology, medicinal chemistry, and preclinical models of behaviour and disease. In 2017, he was elected a Fellow of the Australian Academy of Health and Medical Sciences, in 2018 as the potential of certain drugs, like flumazenil, as 'nails' or compounds that could be developed into medicines

computational and mathematical modelling, structural and chemical biology, molecular and cellular pharmacology, medicinal chemistry, and preclinical models of behaviour and disease. In 2017, he was elected a Fellow of the Australian Academy of Health and Medical Sciences, in 2018 as

computational and mathematical modelling, structural and chemical biology, molecular and cellular pharmacology, medicinal chemistry, and preclinical models of behaviour and disease. In 2017, he was elected a Fellow of the Australian Academy of Health and Medical Sciences, in 2018 as

pharmacology - UK April 3 - 6, 2025 | ASPET 2025 - USA NEW April 14 - 17, 2025 | 20th Drug Discovery Chemistry NEW May 1 - 2, 2025 | 5th Ace Drug Discovery Summit 2025 - USA NEW May 12 - 15, 2025 | ACSMEDI-EFMC Medicinal Chemistry Frontiers 2025 - USA May 12 - 15, 2025 | PEGS 2025 - USA May 15 - 17, 2025 | 23rd GPCR Retreat University Structural Biologist - Confo Therapeutics Associate Director/Director, Platform & Hit-ID Chemistry University of Barcelona GPCR Molecular Pharmacologist - Schrödinger Scientist - Biology - Superluminal Medicines

Clinical Pharmacology GPCR Jobs Structural Biologist Associate Director/Director, Platform & Hit-ID Chemistry Pharmacologist Scientist - Biology Scientist I Cell Biology - Tectonic Therapeutic Senior Principal Scientist, Medicinal Chemistry PhD fellowship in GPCR mechanosensing GPCR Activation and Signaling Lineage-Specific Class-A

Dylan Eiger About Dylan Eiger Dylan Eiger is currently an MD/Ph.D. student at Duke University School of Medicine He received his B.S. in Chemistry from Duke University in 2016 where he worked in the lab of Dr. Stephen Craig and studied polymer chemistry and material science. After finishing his MD/Ph.D., Dylan plans to complete his residency training in Internal Medicine and

Human Health, as well as the Dean of The Graduate School of Biomedical Sciences at the Icahn School of Medicine A native of Italy, she received her Bachelor’s and Master’s degrees in Chemistry from the University She pursued a Ph.D. in Computational Chemistry at the Second University of Naples and a postdoctorate Marta Filizola on the web Icahn School of Medicine at Mount Sinai Filizola Lab Wikipedia Twitter Linkedin

Sudarshan Rajagopal is a physician-scientist and is currently an Associate Professor of Medicine and Biochemistry at Duke University School of Medicine. He obtained his B.S. in Chemistry from The University of Chicago in 1998 and subsequently enrolled in the Medical Scientist Training Program at The University of Chicago. He then joined the Internal Medicine Residency training program at Duke University Medical Center.

Hamm 2 1 Department of Medicine, Division of Cardiovascular Medicine, Vanderbilt University Medical Center She held faculty appointments at the University of Illinois at Chicago School of Medicine and Northwestern Schizophrenia and Depression, the Faculty of the Year award from the University of Illinois College of Medicine , and the Stanley Cohen Award “For Research Bringing Diverse Disciplines, such as Chemistry or Physics the Fritz Lipmann Lecture at ASBMB in 2001. " Heidi Hamm on the web The Hamm Lab Vanderbilt School of Medicine

After spending two years at the Cleveland Institute of Art, he earned degrees in Biochemistry and Chemistry recruited to the Molecular and Cellular Pharmacology Department at the University of Miami Miller School of Medicine sequence- and structure-based informaticist, computational geometer, virtual screener, and Python, medical Daniel Isom on the web Isom Lab University of Miami Miller School of Medicine LinkedIn X (Twitter) BlueSky

Sudarshan Rajagopal obtained his B.S. in Chemistry from The University of Chicago in 1998. He subsequently enrolled in the Medical Scientist Training Program at The University of Chicago. He then joined the Internal Medicine Residency training program at Duke University Medical Center. After completing his training in clinical cardiology, he started as an Assistant Professor of Medicine at Duke University School of Medicine.

visualization tools changed our understanding of GPCR signaling in metabolic tissues What collaborative chemistry innovation with the need for reproducible, well-controlled functional assays Worked across disciplines where chemistry David Hodson is the Robert Turner Professor of Diabetic Medicine at the University of Oxford , working David Hodson on the Web Radcliffe Department of Medicine Islet Biology Lab University of Birmingham Enjoying

He studied Medicine in Milan and Stockholm, and obtained a PhD in Molecular Medicine and a Clinical Specialisation He leads a multidisciplinary research team comprising biologists, chemists, physicists, engineers and has been published in prestigious scientific journals such as Nature, Cell, New England Journal of Medicine and committees, including the ENDO Annual Meeting Steering Committee and the MRC Molecular & Cellular Medicine

Terry Kenakin After obtaining a BSc in chemistry at the University of Alberta Edmonton Canada, Terry received his Ph.D. in Pharmacology from the University of Alberta, Department of Chemistry, Canada. Since 2011, Terry works at the Department of Pharmacology at the University of North Carolina School of Medicine

John Janetzko "I received my Honors BSc in Chemistry from the University of Toronto in 2011, with a focus on synthetic organic and inorganic chemistry. Following this, I pursued graduate studies in Chemistry at Harvard University. He participated in various academic competitions, including math, physics, and chemistry contests. John's Chemistry Olympiad and GPCR Journey John shared his experience with the Chemistry Olympiad program

Lefkowitz, M.D., 2012 Nobel Prize in Chemistry, which he shared with Dr. Brian Kobilka . Duke Professor of Medicine and Professor of Biochemistry, Chemistry, and Pathology at the Duke University Medical Center. He began his career in the late 1960s and has been an Investigator of the Howard Hughes Medical Institute

Osteoarthritis (OA) Severity About Amr Mousa "I am currently a Ph.D. student at the Schulich School of Medicine Janicot "After graduating as an undergrad from Ursinus College, I joined the Johns Hopkins School of Medicine of Angiotensin Receptor Pharmacology About Meredith Skiba "Meredith completed her PhD in Biological Chemistry

Nagarajan Vaidehi, Ph.D., is professor and chair of the Department of Computational and Quantitative Medicine Vaidehi received her Ph.D. in quantum chemistry from the Indian Institute of Technology in India, where

Ajay Yekkirala is a GPCR pharmacologist, biotech entrepreneur, and co-founder of Superluminal Medicines Why This Matters Translating basic GPCR science into actual medicines is broken. Ajay’s work sits at the intersection of GPCR biology, AI, and translational medicine. Ajay Yekkirala on the web Superluminal Medicines LinkedIn Tune in now to hear how asking “what if?” led Ajay Yekkirala to reshape the future of GPCR-targeted medicine. Enjoying the Dr. GPCR Podcast?

Caron and his family moved to Durham, NC in 1977, following receipt of his BSc in Chemistry from Laval He joined the faculty of Laval University School of Medicine in 1975 and then returned to join Duke’s Caron was an investigator of the Howard Hughes Medical Institute from 1992 to 2004, a member of the American